Journal articleJournal of Personalized Medicine · October 1, 2026
There was an error in the original publication [1]. The second MPSIIIB patient fibroblast line, GM01426, was erroneously described as a compound heterozygous genotype. The correct genotype is homozygous for a G>A substitution at nucleotide 457 of the NAGLU ...
Full textCite
Journal articleJournal of Personalized Medicine · July 1, 2026
Background: Mucopolysaccharidosis type IIIB (MPSIIIB, Sanfilippo syndrome type B) is a rare lysosomal storage disease caused by deficiency of alpha-N-acetylglucosaminidase (NAGLU) enzyme, leading to progressive accumulation of heparan sulfate and severe ne ...
Full textCite
Journal articleJ Transl Med · January 7, 2025
BACKGROUND: Glioblastoma (GBM) is a rare brain cancer with an exceptionally high mortality rate, which illustrates the pressing demand for more effective therapeutic options. Despite considerable research efforts on GBM, its underlying biological mechanism ...
Full textLink to itemCite